Provided herein are formulations of acid labile drugs, such as proton pumpinhibitors (PPI). The formulations comprise a PPI and a liquid vehicletypically having a pH greater than 6.5 and a viscosity sufficient to maintaina uniform suspension of the PPI for 15 minutes.